SCHEMBL19730090

SCHEMBL19730090

COc1cc(CC(O)COS(=O)(=O)c2ccc(C)cc2)cc(OC)c1C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
ALDH1A1 P00352 6/20 0.39
GFER P55789 1/20 0.39
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 2/20 0.37
KMT2A Q03164 2/20 0.37
PAX8 Q06710 1/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
APP P05067 1/20 0.36
HPGD P15428 1/20 0.36
KDM4E B2RXH2 1/20 0.35
STAT3 P40763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19738037 0.84 POLB (0.40) POLBALDH1A1LMNASMN1; SMN2GAA
SCHEMBL7925816 0.80 GAA (0.49) POLBALDH1A1LMNAGAAKMT2A
SCHEMBL21378598 0.80 GAA (0.49) POLBALDH1A1LMNAGAAKMT2A
SCHEMBL7933300 0.80 GAA (0.49) POLBALDH1A1LMNAGAAKMT2A
SCHEMBL140992 0.79 STAT3 (0.46) ALDH1A1GAAKMT2AMEN1STAT3
SCHEMBL3295031 0.78 EGFR (0.40) POLBALDH1A1GFERLMNASMN1; SMN2
SCHEMBL9484674 0.77 ALDH1A1 (0.43) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL17929597 0.77 ALDH1A1 (0.43) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL17480135 0.77 ALDH1A1 (0.43) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL9585334 0.76 CYP1A2 (0.54) ALDH1A1LMNASMN1; SMN2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170360665-A1 NOVEL 1-PHENYLMONO- OR -POLYHYDROXYPROPANE COMPOUNDS, COMPOSITIONS AND COSMETIC USES THEREOF L'OREAL (FR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170360665-A1 NOVEL 1-PHENYLMONO- OR -POLYHYDROXYPROPANE COMPOUNDS, COMPOSITIONS AND COSMETIC USES THEREOF GLA, PAH, P4HA1 POLB 661/4885ALDH1A1 52/4885GFER 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.